PATENT CLAIM ANALYSIS

Application Number: 15743324
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "019400"]

Abstract:
Disclosed are compositions, kits, and methods for treating and/or diagnosing cancer in a subject in need thereof. The compositions, kits, and methods may be used to treat and/or diagnose cancers associated with BST-2 expression and/or BST-2 biological activity. Also disclosed are reagents that inhibit dimerization of BST-2 which may be administered as therapeutic agents for inhibiting BST-2 biological activity and treating cancers associated with BST-2 biological activity.

Claim (Index 4):
The method of  claim 1 , wherein the cancer is associated with BST-2 biological activity and the method comprises administering a therapeutic agent that inhibits the biological activity of BST-2.

Metadata:
- Claim Count in Document: 10.0
- Percentile: 86.0
- Lexical Diversity: 1.64444
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12730043', '13969917', '15587262', '14505977', '13320729']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7921261451672299
- 35 USC 102 Novelty (BERT): 0.5260320001057768
- Combined Prediction Score: 0.7655167306610846
- Mean Citation Score: 315.692682
- Max Citation Score: 321.6683
- Similarity Product: 197.6870422090292

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test